Diagnostics & Research
The Diagnostics & Research industry has a total of 56 stocks, with a combined market cap of $750.9 billion, total revenue of $158.34 billion and a weighted average PE ratio of 68.99.
Market Cap
750.90B
Revenue
158.34B
Profits
10.88B
PE Ratio
68.99
Profit Margin
6.87%
Dividend Yield
0.20%
56 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 219.86B | 0.30% | 1,262,871 | 42.37B |
| 2 | DHR | Danaher Corporation | 176.42B | 0.06% | 1,467,601 | 23.74B |
| 3 | A | Agilent Technologies, Inc. | 43.55B | -0.05% | 1,123,970 | 6.51B |
| 4 | IQV | IQVIA Holdings Inc. | 37.16B | -0.47% | 1,689,381 | 15.32B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 35.23B | 0.67% | 311,234 | 3.84B |
| 6 | MTD | Mettler-Toledo International Inc. | 27.87B | -0.28% | 61,068 | 3.76B |
| 7 | WAT | Waters Corporation | 24.24B | -1.35% | 300,155 | 2.91B |
| 8 | NTRA | Natera, Inc. | 22.72B | 2.75% | 1,778,332 | 1.53B |
| 9 | ILMN | Illumina, Inc. | 22.07B | -1.55% | 1,425,760 | 4.39B |
| 10 | LH | Labcorp Holdings Inc. | 20.24B | -0.84% | 280,869 | 12.71B |
| 11 | DGX | Quest Diagnostics Incorporated | 16.87B | -0.97% | 369,669 | 9.54B |
| 12 | ICLR | ICON Public Limited Company | 16.76B | -1.01% | 422,588 | 8.31B |
| 13 | RVTY | Revvity, Inc. | 14.99B | -0.60% | 669,187 | 2.72B |
| 14 | MEDP | Medpace Holdings, Inc. | 10.72B | -0.58% | 81,179 | 2.07B |
| 15 | QGEN | Qiagen N.V. | 10.50B | -0.53% | 968,816 | 1.97B |
| 16 | EXAS | Exact Sciences Corporation | 10.12B | 0.80% | 1,926,725 | 2.69B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.56B | -1.38% | 637,346 | 4.06B |
| 18 | GH | Guardant Health, Inc. | 5.81B | 4.25% | 5,024,776 | 692.26M |
| 19 | RDNT | RadNet, Inc. | 4.73B | 6.05% | 1,558,027 | 1.77B |
| 20 | SHC | Sotera Health Company | 3.85B | 2.18% | 723,327 | 1.12B |
| 21 | VCYT | Veracyte, Inc. | 3.34B | -1.20% | 422,955 | 425.33M |
| 22 | TWST | Twist Bioscience Corporation | 3.12B | 3.89% | 560,068 | 312.97M |
| 23 | NEOG | Neogen Corporation | 2.59B | 1.87% | 1,829,446 | 913.83M |
| 24 | NEO | NeoGenomics, Inc. | 1.86B | 2.15% | 509,833 | 644.12M |
| 25 | CDNA | CareDx, Inc | 1.23B | 1.37% | 421,778 | 312.78M |
| 26 | MYGN | Myriad Genetics, Inc. | 1.12B | -2.43% | 451,710 | 823.60M |
| 27 | OPK | OPKO Health, Inc. | 992.38M | -1.67% | 1,357,987 | 711.41M |
| 28 | GRAL | GRAIL, Inc. | 756.35M | 21.74% | 2,528,151 | 117.67M |
| 29 | CSTL | Castle Biosciences, Inc. | 744.43M | -0.52% | 348,508 | 311.88M |
| 30 | FLGT | Fulgent Genetics, Inc. | 518.75M | -3.80% | 177,413 | 277.76M |
| 31 | PSNL | Personalis, Inc. | 401.26M | 1.80% | 1,538,651 | 87.49M |
| 32 | ACRS | Aclaris Therapeutics, Inc. | 277.10M | -0.38% | 638,928 | 27.08M |
| 33 | BDSX | Biodesix, Inc. | 149.25M | -4.11% | 1,022,484 | 65.56M |
| 34 | NOTV | Inotiv, Inc. | 113.95M | -3.95% | 272,200 | 490.74M |
| 35 | FONR | FONAR Corporation | 98.81M | 1.58% | 13,038 | 102.01M |
| 36 | MDXH | MDxHealth SA | 94.58M | 0.50% | 72,544 | 84.71M |
| 37 | ME | 23andMe Holding Co. | 90.94M | -1.68% | 67,385 | 193.26M |
| 38 | PRE | Prenetics Global Limited | 71.59M | -2.33% | 3,597 | 25.56M |
| 39 | STIM | Neuronetics, Inc. | 70.71M | 4.02% | 292,684 | 72.71M |
| 40 | XGN | Exagen Inc. | 70.55M | -0.25% | 85,160 | 55.75M |
| 41 | BNR | Burning Rock Biotech Limited | 69.86M | -3.27% | 5,939 | 72.83M |
| 42 | VNRX | VolitionRx Limited | 58.25M | -0.22% | 259,745 | 1.29M |
| 43 | ENZ | Enzo Biochem, Inc. | 34.95M | -0.98% | 45,005 | 30.31M |
| 44 | OCX | OncoCyte Corporation | 33.33M | -6.60% | 113,699 | 709.00K |
| 45 | PRPH | ProPhase Labs, Inc. | 12.65M | -12.97% | 1,000,979 | 12.75M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 10.21M | -2.24% | 358,920 | 9.37M |
| 47 | PRPO | Precipio, Inc. | 9.87M | 1.14% | 4,070 | 17.41M |
| 48 | APDN | Applied DNA Sciences, Inc. | 9.05M | -3.89% | 1,551,576 | 3.43M |
| 49 | MYNZ | Mainz Biomed N.V. | 8.81M | -10.20% | 74,892 | 917.20K |
| 50 | AWH | Aspira Women's Health Inc. | 8.33M | 2.02% | 64,074 | 8.96M |
| 51 | CHEK | Check-Cap Ltd. | 7.43M | 3.25% | 54,940 | - |
| 52 | STRR | Star Equity Holdings, Inc. | 7.07M | -1.92% | 11,536 | 50.38M |
| 53 | XWEL | XWELL, Inc. | 6.68M | - | 60,989 | 33.83M |
| 54 | TTOO | T2 Biosystems, Inc. | 4.83M | -0.17% | 1,461,617 | 7.68M |
| 55 | NDRA | ENDRA Life Sciences Inc. | 2.99M | -6.54% | 15,788 | - |
| 56 | ISPC | iSpecimen Inc. | 2.19M | -5.39% | 279,876 | 10.39M |